Association of patient mismatch HLA-DP group and HLA-DPB1 TCE mismatching
| . | HR . | 95% CI . | P . | N . | |
|---|---|---|---|---|---|
| Patient mismatch HLA-DP group effect | |||||
| PM | DP2 group | 1.00 | 566 | ||
| DP5 group | 1.42* | 1.15-1.75 | .001 | 388 | |
| Non-PM | DP2 group | 1.00 | 91 | ||
| DP5 group | 0.76* | 0.53-1.09 | .138 | 241 | |
| HLA-DPB1 TCE mismatching effect | |||||
| DP2 group | PM | 1.00 | 566 | ||
| Non-PM | 1.67† | 1.20-2.31 | .002 | 91 | |
| DP5 group | PM | 1.00 | 388 | ||
| Non-PM | 0.94† | 0.74-1.20 | .638 | 241 | |
| . | HR . | 95% CI . | P . | N . | |
|---|---|---|---|---|---|
| Patient mismatch HLA-DP group effect | |||||
| PM | DP2 group | 1.00 | 566 | ||
| DP5 group | 1.42* | 1.15-1.75 | .001 | 388 | |
| Non-PM | DP2 group | 1.00 | 91 | ||
| DP5 group | 0.76* | 0.53-1.09 | .138 | 241 | |
| HLA-DPB1 TCE mismatching effect | |||||
| DP2 group | PM | 1.00 | 566 | ||
| Non-PM | 1.67† | 1.20-2.31 | .002 | 91 | |
| DP5 group | PM | 1.00 | 388 | ||
| Non-PM | 0.94† | 0.74-1.20 | .638 | 241 | |